{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:37:50Z","timestamp":1769168270704,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ygyno.2019.09.028","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T07:51:40Z","timestamp":1570780300000},"page":"429-435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Adjuvant vaginal brachytherapy and chemotherapy versus pelvic radiotherapy in early-stage endometrial cancer: Outcomes by risk factors"],"prefix":"10.1016","volume":"155","author":[{"given":"Ken","family":"Tatebe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmin","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina H.","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2019.09.028_bib1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","article-title":"Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium","volume":"40","author":"Morrow","year":"1991","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2019.09.028_bib2","first-page":"419","article-title":"Postoperative external Irradiation and prognostic parameters in stage I endometrial carcinoma","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2019.09.028_bib3","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer","volume":"51","author":"Bosse","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2019.09.028_bib4","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ygyno.2011.09.005","article-title":"The importance of chemotherapy and radiation in uterine papillary serous carcinoma","volume":"123","author":"Viswanathan","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2019.09.028_bib5","first-page":"e631","article-title":"Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trail for endometrial carcinoma","volume":"81","author":"Creutzberg","year":"2011","journal-title":"IJROBP"},{"key":"10.1016\/j.ygyno.2019.09.028_bib6","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41416-018-0310-8","article-title":"Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma","volume":"119","author":"Wortman","year":"2018","journal-title":"Br. J. Canc."},{"issue":"3","key":"10.1016\/j.ygyno.2019.09.028_bib7","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A\u00a0phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.09.028_bib8","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"issue":"9717","key":"10.1016\/j.ygyno.2019.09.028_bib9","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus\u00a0pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2)","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.ygyno.2019.09.028_bib10","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2008.20.2424","article-title":"Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer","volume":"27","author":"Nout","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ygyno.2019.09.028_bib11","article-title":"Phase III trial: adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel\/carboplatin in high-intermediate and high-risk early stage endometrial cancer","volume":"18","author":"Randall","year":"2019","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ygyno.2019.09.028_bib12","series-title":"Mathematical Methods of Statistics","author":"Cramer","year":"1946"},{"issue":"1","key":"10.1016\/j.ygyno.2019.09.028_bib13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ygyno.2017.11.010","article-title":"Adjuvant therapy in patients with clear cell endometrial carcinoma","volume":"148","author":"Nieto","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.09.028_bib14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3)","volume":"19","author":"de Boer","year":"2018","journal-title":"Lancet Oncol."},{"issue":"9658","key":"10.1016\/j.ygyno.2019.09.028_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","article-title":"Efficacy of systemic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial)","volume":"373","author":"Kitchener","year":"2009","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.ygyno.2019.09.028_bib16","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","article-title":"Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma","volume":"100","author":"Panici","year":"2008","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2019.09.028_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ygyno.2011.09.017","article-title":"Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer","volume":"142","author":"Guntupalli","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2019.09.028_bib18","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ygyno.2004.11.033","article-title":"Lymphvascular space involvement: an independent prognostic factor in endometrial cancer","volume":"96","author":"Bri\u00ebt","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2019.09.028_bib19","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ygyno.2016.05.037","article-title":"Lymphovascular space invasion in uterine corpus cancer","volume":"142","author":"Neal","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"15","key":"10.1016\/j.ygyno.2019.09.028_bib20","article-title":"A\u00a0randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel vs. carboplatin and paclitaxel for optimally debulked, advanced endometrial carcinoma","volume":"35","author":"Matei","year":"2017","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ygyno.2019.09.028_bib21","first-page":"1625","volume":"vol. 104","author":"Kong","year":"2012"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819315410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819315410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:45:31Z","timestamp":1758771931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825819315410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0090825819315410"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.09.028","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant vaginal brachytherapy and chemotherapy versus pelvic radiotherapy in early-stage endometrial cancer: Outcomes by risk factors","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.09.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}